clopidogrel has been researched along with Cardiac Conduction Defect in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, PW; Bansilal, S; Becker, RC; Cannon, CP; Clare, RM; Davoudi, F; Held, C; Himmelmann, A; James, SK; Mahaffey, KW; Pieper, KS; Schulte, PJ; Scirica, BM; Steg, PG; Storey, RF; Wallentin, L | 1 |
1 trial(s) available for clopidogrel and Cardiac Conduction Defect
| Article | Year |
|---|---|
Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis.
Topics: Acute Coronary Syndrome; Aged; Arrhythmias, Cardiac; Cardiac Conduction System Disease; Clopidogrel; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Ticagrelor | 2018 |